Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Recludix Pharma
Biotech
Sanofi pays $125M, offers up to $1.2B biobucks for Recludix deal
Sanofi is paying Recludix $125 million and offering up more than $1.2 billion biobucks for an immunological and inflammatory disease pact.
Gabrielle Masson
Jul 20, 2023 8:00am
Moderna promotes Andres to new strategy role—Chutes & Ladders
Sep 30, 2022 9:30am
FDA Califf, Biogen exec Sandrock, Pfizer CFO—Chutes & Ladders
Nov 19, 2021 9:30am
Recludix emerges with $60M, Seagen exec Nancy Whiting at helm
Nov 15, 2021 8:00am